2026 Optometrist Report

2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

Recently Published
Systems That Keep Patients Buying Lenses In-House
PRACTICE METRICS & ANALYTICS
Systems That Keep Patients Buying Lenses In-House

Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.

A Concise Workflow for Identifying and Monitoring Glaucoma Suspects
CLINICAL GUIDES
A Concise Workflow for Identifying and Monitoring Glaucoma Suspects

Review step by step pearls for diagnosing and managing glaucoma suspects, and how a shift toward earlier procedural intervention is reducing drop burden.

Nick Bruns, OD, FAAONovember 11, 2026
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
CLINICAL STUDIES & TRIALS
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer

Join Drs. Rishi Singh and Donald D'Amico to review the results of the phase 3 BRUNELLO trial of Remigromig for DME and implications for the BAROLO trial.

2026 Contact Lens Report

2026 Contact Lens Report

Download the free report to learn how optometrists are managing their contact lens practices in 2026!

Learn More
Latest Stories
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3B
November 16, 2026
Johnson & Johnson to acquire Ollin Biosciences in deal worth up to $3.3B

Pending transaction includes phase 3 funding for OLN324, an investigational bispecific antibody under evaluation for wet AMD and DME.

i-Lumen reports new i-SIGHT data on retinal bioelectric stimulation for dry AMD
November 16, 2026
i-Lumen reports new i-SIGHT data on retinal bioelectric stimulation for dry AMD

Expanded clinical findings from U.S.-based feasibility trial include a ≥10-ETDRS letter improvement among over 50% of treated patients.

IMVIONIX debuts with acquisition of BEOVU's North American rights
November 13, 2026
IMVIONIX debuts with acquisition of BEOVU's North American rights

Biotech company launches to commercial space; secures U.S. and Canadian exclusive rights to the FDA-approved injection for wet AMD and DME.

Clinical
The Role of Tear Film Biomarkers in Diagnosing and Managing DED
CLINICAL GUIDES
The Role of Tear Film Biomarkers in Diagnosing and Managing DED

Sit down with Drs. Damon Dierker and Jerry Robben to review how to interpret and integrate tear film biomarkers into dry eye disease management workflows.

Geographic Atrophy: Why Early Detection is the New Standard of Care
RETINAL DISEASE
Geographic Atrophy: Why Early Detection is the New Standard of Care

How clinical data from the past three years have shifted the treatment landscape and reformed the clinical calculus when it comes to managing geographic atrophy patients.

Saagar Pandit, MD, MPHNovember 13, 2026
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes
CLINICAL STUDIES & TRIALS
24-Month ELIOS Data: IOP, Medication, and Safety Outcomes

Sit down with Drs. Mark Gallardo and Steven Sarkisian to review 24-month findings from the pivotal trial for ELIOS combined with cataract surgery.

Careers
Systems That Keep Patients Buying Lenses In-House
PRACTICE METRICS & ANALYTICS
Systems That Keep Patients Buying Lenses In-House

Consider approaches optometrists can take to increase the number of patients who purchase contact lenses at the office instead of online retailers.

2026 Optometrist Report
OPTOMETRY INDUSTRY INFO
2026 Optometrist Report

Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.

Natalie Osayande, OD, MSNovember 9, 2026
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
PRESBYOPIA
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice

Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.

Sponsored Content
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
PRIMARY CARE

The Ultimate Guide to TOTAL30® Multifocal for Astigmatism

Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1

Our industry partners

ZEISS
National Vision
EssilorLuxottica
Essilor
Johnson & Johnson Vision
ZEISS Professional Education

Find your next eyecare job

Browse Eyecare Jobs (1,000+)Post a Job

Find your next eyecare job